doi:10.1080/07853890701753664 16Soria A, Bernier C, Veyrac G, Barbaud A, Puymirat E, Milpied B
Results from a post hoc subgroup analysis of the SURMOUNT-1 study (NCT04184622), published this year [87] , demonstrated that among 32 pathogenic MC4R variant carriers (1.4% of the study population) with a median age of 41.06 years and a BMI 40 kg/m 2 , treatment with tirzepatide for 72 weeks resulted in an 18.3% reduction in body weight from baseline
However, these arrangements have become less frequent lately
Remember, weight loss is not an overnight process
For more than 20 years, we have been a leader in IV iron therapy
Synergistic Benefits: Stronger immune defense Faster healing and regeneration Reduced systemic inflammation Peptides: Tesamorelin + CJC/Ipamorelin + BPC-157 Targets metabolism, recovery, and tissue protection ideal for athletes and longevity-focused individuals